• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . Seroprevalence of SARS-CoV-2-Specific Antibodies, Faroe Islands

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2020 Jul 29;26(11).
doi: 10.3201/eid2611.202736. Online ahead of print.
Seroprevalence of SARS-CoV-2-Specific Antibodies, Faroe Islands

Maria Skaalum Petersen, Marin Str?m, Debes Hammershaimb Christiansen, J?gvan P?ll Fjallsbak, Eina Hansen Eliasen, Malan Johansen, Anna Sof?a Veyhe, Marnar Fr??heim Kristiansen, Shahin Gaini, Lars Fodgaard M?ller, Bjarni Steig, P?l Weihe

Abstract

We conducted a nationwide study of the prevalence of severe acute respiratory syndrome coronavirus 2 infection in the Faroe Islands. Of 1,075 randomly selected participants, 6 (0.6%) tested seropositive for antibodies to the virus. Adjustment for test sensitivity and specificity yielded a 0.7% prevalence. Our findings will help us evaluate our public health response.

Keywords: 2019 novel coronavirus disease; COVID-19; Denmark; Faroe Islands; SARS-CoV-2; antibodies; coronavirus disease; respiratory diseases; seroprevalence; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.
 
Back
Top Bottom